Alerts will be sent to your verified email
Verify EmailZYDEN
Zyden Gentec
|
MPS Pharmaa
|
Kobo Biotech
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-24.76 % | -41.86 % | -1.77 % |
5yr average Equity Multiplier
|
2.0 | 3.24 | 4.06 |
5yr Average Asset Turnover Ratio
|
0.21 | 0.0 | 0.54 |
5yr Avg Net Profit Margin
|
-137.59 % | -5434.45 % | -3.79 % |
Price to Book
|
n/a | 4.63 | 0.0 |
P/E
|
n/a | 0.0 | 0.0 |
5yr Avg Cash Conversion Cycle
|
785.76 Days | 0.0 | 0.0 |
Inventory Days
|
134.34 Days | 1258.79 Days | 89.28 Days |
Days Receivable
|
803.05 Days | 0.0 | 0.0 |
Days Payable
|
421.99 Days | 414.72 Days | 147.48 Days |
5yr Average Interest Coverage Ratio
|
-2.08 | -816.29 | 0.99 |
5yr Avg ROCE
|
-6.92 % | -41.48 % | 11.79 % |
5yr Avg Operating Profit Margin
|
-95.87 % | -3500.38 % | 8.83 % |
5 yr average Debt to Equity
|
0.68 | 1.97 | 1.62 |
5yr CAGR Net Profit
|
-1.66 % | -6.64 % | n/a |
5yr Average Return on Assets
|
-15.88 % | -13.25 % | -0.89 % |
Shareholdings
|
|||
Promoter Holding
|
0.0 | 35.89 % | 44.95 % |
Share Pledged by Promoters
|
0.0 | 16.04 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-17.28 % | 0.0 | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Zyden Gentec
|
MPS Pharmaa
|
Kobo Biotech
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|